Robert Amato

Professor and DirectorUniversity of Texas Health Center at HoustonUnited States of America

Robert Amato is the Chief of the Oncology Division and a Professor at the University of Texas Medical School at Houston and Director of Oncology at the Memorial Hermann Cancer Center. He obtained his Doctor of Osteopathic Medicine from the University of North Texas before becoming a fellow in Medical Oncology at MD Anderson Cancer Center. Dr. Amato is one of the world’s leading experts in the treatment of genitourinary cancer. Early in his career, his research helped make testicular cancer a highly treatable disease. His current research focuses on molecular-targeted therapeutics, halting the progression of metastatic kidney and prostate cancers, the further development of immunotherapies, and determining how his studies may be used to treat genitourinary cancer.

1books edited

1chapters authored

Latest work with IntechOpen by Robert Amato

The field of renal cell cancer has undergone a significant resurgence. This book summarizes up-to-date research and innovative ideas for the future in this rapidly changing field, which encompasses medicine, surgery, radiation oncology, basic science, pathology, radiology, and supportive care. This book is aimed at the clinician or scientist who has an interest in renal cell cancer, whether they are academic or nonacademic. The book covers tumor biology, molecular biology, surgery techniques, radiation therapy, personal testimonies, and present and future treatments of the disease that are on the horizon. The goal was to produce a textbook that would act as an authoritative source for scientists and clinicians and interpret the field for trainees in surgery, medicine, radiation oncology, and pathology.

Go to the book